L-精氨酸治疗丙戊酸过量:五例临床病例
本文为五例丙戊酸过量伴高氨血症(血氨>80 μg/dL)并出现嗜睡或昏迷患者的观察性研究,数据回顾性收集。给予L-精氨酸后,五例患者血氨均下降(例I 381→39、例II 281→50、例III 669→74、例IV 447→56、例V 202→60 μg/dL)。例I和II在给予L-精氨酸前已行血液透析并给予L-肉碱;例III在开始L-精氨酸后才行血液透析;例IV和V仅用L-精氨酸降低血氨。作者认为L-精氨酸可能对部分丙戊酸过量合并高氨血症病例有益,可扩展传统治疗选择。
要点
- 五例丙戊酸过量伴高氨血症(血氨>80 μg/dL)及嗜睡或昏迷患者,给予L-精氨酸后血氨在时间上密切下降。
- 例I血氨从381降至39 μg/dL,例II从281降至50,例III从669降至74,例IV从447降至56,例V从202降至60。
- 例I和II在给L-精氨酸前已行血液透析并给予L-肉碱;例III在开始L-精氨酸后才行血液透析。
- 例IV和V仅用L-精氨酸作为降低血氨的措施。
- 作者认为L-精氨酸可能对部分丙戊酸过量合并高氨血症病例有益,可扩展传统治疗选择。
适用人群与场景
- 丙戊酸过量伴高氨血症(血氨>80 μg/dL)及与丙戊酸过量一致的嗜睡或昏迷症状的患者。
诊断标准与关键阈值
- 高氨血症定义为血氨>80 μg/dL。
- 症状与丙戊酸过量一致,如嗜睡、昏迷。
处置流程与药物剂量
- 对丙戊酸过量伴高氨血症(血氨>80 μg/dL)及嗜睡或昏迷的患者给予L-精氨酸。
- 例I和II在给予L-精氨酸前已行血液透析并给予L-肉碱。
- 例III在开始L-精氨酸后才行血液透析。
- 例IV和V仅用L-精氨酸降低血氨。
研究设计与关键结果
- 观察性研究,五例病例,数据回顾性收集。
- L-精氨酸治疗后血氨下降:例I从381降至39 μg/dL,例II从281降至50,例III从669降至74,例IV从447降至56,例V从202降至60。
- 例I和II在给L-精氨酸前已行血液透析并给予L-肉碱;例III在开始L-精氨酸后才行血液透析;例IV和V仅用L-精氨酸降低血氨。
证据类型、等级与局限
- 证据类型:观察性研究(五例病例),数据回顾性收集。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为L-精氨酸可能对部分丙戊酸过量合并高氨血症病例有益。
- 作者认为L-精氨酸可扩展丙戊酸过量的传统治疗选择。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Valproic acid and its metabolites - particularly valproyl-CoA - are inhibitors of the enzyme N-acetylglutamate synthetase. The amino acid l-arginine can stimulate N-acetylglutamate synthetase activity and could be potentially used therapeutically to correct hyperammonemia caused by valproate therapy or overdose. Severely valproic-acid-poisoned patients are usually treated with l-carnitine or hemodialysis in order to decrease hyperammonemia. We herein report of five cases, in which l-arginine was administered.
METHODS: Observational study on five cases. Patients with hyperammonemia (i.e., ammonia 80 > μg/dL) and symptoms consistent with valproate overdose (i.e., drowsiness, coma) were selected for treatment with l-arginine. Data was collected retrospectively.
RESULTS: l-Arginine decreased ammonia levels in a close temporal relation (case I ammonia in EDTA-plasma [μg/dL] decreased from 381 to 39; case II from 281 to 50; case III from 669 to 74; case IV from 447 to 56; case V from 202 to 60). In cases I and II, hemodialysis was performed and l-carnitine was given before the administration of l-arginine. In case III, hemodialysis was performed after the administration of l-arginine was already started. In cases IV and V, treatment with l-arginine was the sole measure to decrease ammonia levels in plasma.
CONCLUSION: The results suggest that l-arginine may be beneficial in selected cases of valproate overdose complicated by hyperammonemia. l-Arginine could extend our conventional treatment options for valproic acid overdose.
参考来源
- Schrettl V, Felgenhauer N, Rabe C, et al. L-Arginine in the treatment of valproate overdose - five clinical cases. Clin Toxicol (Phila). 2017. PMID: 28152637. doi:10.1080/15563650.2017.1284333
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。